Company: MDCXW
Filing Date: 2025-04-25
Form Type: DRS
Source: 0001062993-25-007956
Chunk: 4

Company: Medicus Pharma Ltd.
Filing Date: 2025-04-25
Form: DRS
Chunk 4
---
 offering to adequately fund the intended uses of the proceeds as described in this prospectus. All proceeds from this offering will become immediately available to us and may be used as they are accepted. Purchasers of the Units will not be entitled to a refund and could lose their entire investments. See “Risk Factors” for more information regarding risks related to this offering. We will bear all costs associated with the offering. See “Plan of Distribution” for more information regarding these arrangements.

We are an "emerging growth company" and a "smaller reporting company" under applicable U.S. Securities and Exchange Commission rules and will be eligible for reduced public company disclosure requirements. See"Prospectus Summary-Implications of Being an Emerging Growth Company" and "Prospectus Summary-Implications of Being a Smaller Reporting Company."

<div align='center'>____________________________</div>

Investing in our securities involves risks. See " Risk Factors" beginning on page 10 of this prospectus to read about factors you should consider before buying our securities.

|                           | Per Unit |     | Total |
|:--------------------------|:---------|:----|:------|
| Public offering price     | $        |     | $     |
| Placement agent fees(1)   | $        |     | $     |
| Proceeds, before expenses | $        |     | $     |

(1)We have engaged Maxim Group LLC (the “agent”) to act as placement agent for this offering, in exchange for a fee of 7.5% of the aggregate offering price of the Units sold in this offering. We have also agreed to reimburse the agent for certain expenses. For additional agent compensation information, see "Plan of Distribution" on page 135.

| CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD. 
 PURSUANT TO 17 C.F.R. SECTION 200.83                    |

Neither the U.S. Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

The agent expects to deliver the common shares and warrants against payment as set forth under "Plan of Distribution"on or about, 2025.

<div align='center'>____________________________

Maxim Group LLCThe date of this prospectus is , 2025</div>

| CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD. 
 PURSUANT TO